341 related articles for article (PubMed ID: 19413891)
21. Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma.
Do B; Lossos IS; Thorstenson Y; Oefner PJ; Levy R
Leuk Lymphoma; 2003 Aug; 44(8):1317-23. PubMed ID: 12952224
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index.
Due H; Brøndum RF; Young KH; Bøgsted M; Dybkær K
BMC Cancer; 2020 Mar; 20(1):237. PubMed ID: 32192453
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
24. The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies.
Fassina A; Marino F; Siri M; Zambello R; Ventura L; Fassan M; Simonato F; Cappellesso R
Lab Invest; 2012 Nov; 92(11):1574-82. PubMed ID: 22964854
[TBL] [Abstract][Full Text] [Related]
25. Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements.
Jardin F; Buchonnet G; Parmentier F; Contentin N; Leprêtre S; Lenain P; Picquenot JM; Laberge S; Bertrand P; Stamatoullas A; D'Anjou J; Tilly H; Bastard C
Leukemia; 2002 Nov; 16(11):2318-25. PubMed ID: 12399978
[TBL] [Abstract][Full Text] [Related]
26. [The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma].
Musilová K; Deván J; Zlámalíková L; Křen L; Móciková H; Procházka V; Mayer J; Trněný M; Janíková A; Mráz M
Klin Onkol; 2017; 30(Supplementum1):163-165. PubMed ID: 28471196
[TBL] [Abstract][Full Text] [Related]
27. Cell of origin of transformed follicular lymphoma.
Kridel R; Mottok A; Farinha P; Ben-Neriah S; Ennishi D; Zheng Y; Chavez EA; Shulha HP; Tan K; Chan FC; Boyle M; Meissner B; Telenius A; Sehn LH; Marra MA; Shah SP; Steidl C; Connors JM; Scott DW; Gascoyne RD
Blood; 2015 Oct; 126(18):2118-27. PubMed ID: 26307535
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.
Roehle A; Hoefig KP; Repsilber D; Thorns C; Ziepert M; Wesche KO; Thiere M; Loeffler M; Klapper W; Pfreundschuh M; Matolcsy A; Bernd HW; Reiniger L; Merz H; Feller AC
Br J Haematol; 2008 Sep; 142(5):732-44. PubMed ID: 18537969
[TBL] [Abstract][Full Text] [Related]
29. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profile of serial samples of transformed B-cell lymphomas.
de Vos S; Hofmann WK; Grogan TM; Krug U; Schrage M; Miller TP; Braun JG; Wachsman W; Koeffler HP; Said JW
Lab Invest; 2003 Feb; 83(2):271-85. PubMed ID: 12594241
[TBL] [Abstract][Full Text] [Related]
31. Transformation to diffuse large B-cell lymphoma with germinal center B-cell like subtype and discordant light chain expression in a patient with Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Kobayashi H; Asada N; Egusa Y; Ikeda T; Sakamoto M; Abe M; Ennishi D; Sakata M; Takaki A; Kawahara S; Meguri Y; Nishimori H; Fujii N; Matsuoka KI; Sato Y; Yoshino T; Maeda Y
Int J Hematol; 2021 Sep; 114(3):401-407. PubMed ID: 33907976
[TBL] [Abstract][Full Text] [Related]
32. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
33. Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome.
Czuchlewski DR; Csernus B; Bubman D; Hyjek E; Martin P; Chadburn A; Knowles DM; Cesarman E
Am J Clin Pathol; 2008 Dec; 130(6):957-62. PubMed ID: 19019774
[TBL] [Abstract][Full Text] [Related]
34. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
[TBL] [Abstract][Full Text] [Related]
35. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Xu-Monette ZY; Li L; Byrd JC; Jabbar KJ; Manyam GC; Maria de Winde C; van den Brand M; Tzankov A; Visco C; Wang J; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Wang M; Hagemeister FB; Piris MA; Han van Krieken J; Medeiros LJ; Li Y; van Spriel AB; Young KH
Blood; 2016 Dec; 128(26):3083-3100. PubMed ID: 27760757
[TBL] [Abstract][Full Text] [Related]
36. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
37. Survival of patients with transformed lymphoma in the rituximab era.
Guirguis HR; Cheung MC; Piliotis E; Spaner D; Berinstein NL; Imrie K; Zhang L; Buckstein R
Ann Hematol; 2014 Jun; 93(6):1007-14. PubMed ID: 24414374
[TBL] [Abstract][Full Text] [Related]
38. Similar prognosis of transformed and de novo diffuse large B-cell lymphomas in patients treated with immunochemotherapy.
Sorigue M; Garcia O; Baptista MJ; Sancho JM; Tapia G; Mate JL; Feliu E; Navarro JT; Ribera JM
Med Clin (Barc); 2017 Mar; 148(6):243-249. PubMed ID: 28038857
[TBL] [Abstract][Full Text] [Related]
39. Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma.
Ludvigsen M; Madsen C; Kamper P; Hamilton-Dutoit SJ; Bendix K; d'Amore F; Honoré B
Blood Cancer J; 2015 Mar; 5(3):e293. PubMed ID: 25768407
[No Abstract] [Full Text] [Related]
40. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
Scandurra M; Rossi D; Deambrogi C; Rancoita PM; Chigrinova E; Mian M; Cerri M; Rasi S; Sozzi E; Forconi F; Ponzoni M; Moreno SM; Piris MA; Inghirami G; Zucca E; Gattei V; Rinaldi A; Kwee I; Gaidano G; Bertoni F
Hematol Oncol; 2010 Jun; 28(2):62-7. PubMed ID: 20014148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
